Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

August 25, 2015

Primary Completion Date

September 18, 2020

Study Completion Date

September 18, 2020

Conditions
Advanced Solid Tumors
Interventions
DRUG

lurbinectedin (PM01183)

Trial Locations (40)

1000

Institut Jules Bordet, Brussels

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

6500

Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona

12200

Charité Universitätsmedizin Berlin - Campus Benjamin Franklin - Comprehensive Cancer Center, Berlin

13353

Charité - Universitätsmedizin Berlin, Berlin

14004

Complejo Hospitalario Regional Reina Sofía, Córdoba

15006

Complexo Hospitalario Universitario A Coruña, A Coruña

15706

Complexo Hospitalario Universitario de Santiago, Santiago de Compostela

18014

Hospital Universitario Virgen de las Nieves, Granada

20014

Hopsital Universitario Donostia - Donostia Unibertsitate Ospitalea, San Sebastián

20089

Istituto Clinico Humanitas, Rozzano

20090

ASST Monza - Ospedale San Gerardo di Monza Struttura Complessa di Oncologia Medica, Monza

20141

lstituto Europeo di Oncologia, Milan

22185

Skane University Hospital, Lund

28034

Hospital Ramón y Cajal, Madrid

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28050

Hospital Universitario Madrid Sanchinarro, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

29010

Complejo Hospitalario de Especialidades Virgen de la Victoria, Málaga

31008

Complejo Hospitalario De Navarra, Pamplona

31059

Institut Claudius Regaud, Toulouse

33011

Hospital Universitario Central de Asturias, Oviedo

36312

Hospital Universitario Álvaro Cunqueiro, Vigo

46026

Hospital Universitari i Polotècnic la Fe, Valencia

48013

Hospital de Basurto, Bilbao

48121

AUSL Romagna - Ospedale Santa Maria delle Croci, Ravenna

50009

Hospital Universitario Miguel Servet, Zaragoza

75014

Hôpital Cochin, Paris

77030

The University of Texas MD Anderson Cancer Center, Houston

78229

Institute for Drug Development, Cancer Therapy & Research Center at University of Texas Health Science Center, San Antonio

80045

University of Colorado Cancer Center, Aurora

90403

Sarcoma Oncology Research Center, LLC, Santa Monica

94805

Institut Gustave Roussy, Villejuif

02114

Massachussets General Hospital, Boston

02215

Beth Israel Deaconess Medical Centre, Boston

Dana Farber Cancer Institute, Boston

Unknown

Istituto Ortopedico Rizzoli, Bologna

08035

Hospital Universitari Vall D' Hebron, Barcelona

WC1E 6DD

UCL Cancer Institute, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PharmaMar

INDUSTRY